Back to Results
First PageMeta Content
Medicine / Medical equipment / Medical technology / Propel mometasone furoate implant / RTT / Intersect ENT / Sinusitis / Surgical specialties / Sinus / Otorhinolaryngology / Endoscopy / Sinus implant


Intersect ENT Announces Publication of Position Statement from AAO-HNS on Use of Biomaterials Statement Supports Use of PROPEL, the Only FDA-Approved Biomaterial Used to Improve Patient Outcomes in Sinus Procedures Menlo
Add to Reading List

Document Date: 2015-10-21 16:28:17


Open Document

File Size: 21,75 KB

Share Result on Facebook